License to Improvements. Licensor agrees to grant and does hereby grant to Licensee a worldwide, royalty-free, exclusive, non-transferrable license to any and all Improvements to sublicense, manufacture, have manufactured, use, offer for sale, sell, export, and import Licensed Products and Licensed Products protected by Improvements, as defined herein.
License to Improvements. During the term of this Agreement, DYTECH shall deliver to AMEDICA a reasonably detailed written description of any Improvement (the “Improvement Notice”). The Improvement Notice shall be delivered to AMEDICA as soon as practicable after DYTECH develops or discovers the Improvement, but in any event prior to disclosure of such Improvement to any Third Party (except DYTECH’S own professional Third Party patent advisors and lawyers, each of which will be subject to written confidentiality obligations no less stringent than those contained herein). AMEDICA shall have the exclusive right and option, exercisable for a period of [*************] after its receipt of the Improvement Notice, to include the Improvement within the scope of the exclusive license grant of Section 3.1 above by delivering to DYTECH a written notice (the “Exercise Notice”) to such effect. If AMEDICA delivers an Exercise Notice for any Improvement, the scope of the exclusive license grant of Section 3.1 above shall, without any further payment by AMEDICA, be deemed to include such Improvement thereafter.
License to Improvements. Section 3.6 of the Agreement is hereby deleted in its entirety and replaced with the following: License to Improvements. Virgin hereby grants, and shall cause its Affiliates to grant, to MAV a worldwide, royalty-free, perpetual, non-exclusive license to all improvements and enhancements to the items set forth in clauses (a) and (b) of Section 1.6 above, to the extent that such improvements and enhancements are or have been created, invented or first reduced to practice by or on behalf of Virgin or its Affiliates (“Virgin IP”) prior to the end of the Exclusivity Period. Such license includes the right (a) to grant sublicenses thereunder at any time in the Space Tourism Market and (b) to grant sublicenses thereunder with effect at any time following the Exclusivity Period in any market or for any areas or activities.
License to Improvements. Licensee may include any patent application claims covering Improvements as a Licensed Patent under this Agreement at no additional cost other than the costs set forth in this Agreement by providing written notice to Licensor within [***] days after publication of such patent application identifying the Improvement patent applications Licensee chooses to include as a Licensed Patent. If Licensor concurs with such determination, such patent applications will be deemed to be a Licensed Patent effective on Licensee’s notice to Licensor in accordance with Section 14.5 of this Agreement.
License to Improvements. 15 9.6 Sublicenses................................................................................... 15
License to Improvements. Vilmorin hereby grants Agritope a royalty-free, nonexclusive perpetual license to make, use and sell any improvements made by Vilmorin to Agritope's Technology in connection with any Research Project or Modified Crop.
License to Improvements. If Microbot terminates this Agreement without cause pursuant to Section 11.2.1 or TRDF terminates this Agreement in accordance with any of the provisions of Section 11.2 (and except in the case of assignment pursuant to Section 11.3.4), Microbot will, upon TRDF’s first request, grant TRDF and shall cause its Affiliates to grant TRDF a non-exclusive, nontransferable, royalty-bearing license, with the right to sublicense, under Microbot’s rights in Microbot Improvement Patent Rights (as defined below) solely to develop, make and have made, market, offer for sale, sell and import Licensed Products. If TRDF thereafter grants a sublicense under any of such Microbot Improvement Patent Rights, TRDF shall pay Microbot an amount equal to 10% of all Net Proceeds. The provisions of this Section 11.3.3 shall also apply with respect to partial termination of the license granted under Section 3 above pursuant to the provisions of Section 4.5 or 11.2.3 above, but only with respect to the specific family of TRDF Patent Rights with respect to which termination has occurred. For purposes of this Section 11.3.3.1, the following terms shall have the following meanings:
License to Improvements. BMS hereby grants to GI a non-exclusive, ----------------------- royalty-free license to all Improvements, including the right to grant sublicenses, for the sole and exclusive purpose of (a) producing bulk NPA both within and outside the Territory, but only for distribution and sale outside the Territory, (b) developing, using, registering, formulating, filling and finishing, distributing and/or selling Licensed Products outside the Territory and (c) in the event that the Option, the licenses granted to BMS in this Agreement and this Agreement expire or terminate for any reason without BMS having exercised the Option, distributing and selling bulk NPA within the Territory and developing, using, registering, formulating, filling and finishing, distributing and/or selling Licensed Products within the Territory.
License to Improvements. The License Agreement shall contain ----------------------- provisions comparable to those set forth in Section 3.5 of this Agreement, provided that the provisions of Section 3.5(c) of this Agreement shall apply to any termination of the License Agreement not due to GI's breach of the License Agreement.
License to Improvements. Subject to the terms and conditions hereof, ALPHARMA hereby grants to IDEA a nonexclusive, royalty-free, perpetual license, with the right to grant sublicenses subject to the terms hereof, under the Improvements Controlled by ALPHARMA which are made at any time after the Effective Date but before the date of the First Commercial Sale of the first Licensed Product in the U.S., to make, have made, use, sell, offer for sale and import Products outside the Territory and to conduct clinical trials and manufacture Products within the Territory for the purpose of making, having made, using, selling, offering for sale and importing Products solely outside the Territory and to perform IDEA's obligations pursuant to Section 5.1.
